THE ROLE OF MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING (MMRI) IN THE DIFFERENTIAL DIAGNOSIS AND GRADING OF SOFT TISSUE TUMORS
Article Sidebar
Main Article Content
Аннотация:
Soft tissue sarcomas (STS) are a heterogeneous group of rare mesenchymal tumors that account for approximately 1% of all adult malignancies but represent a significant diagnostic and therapeutic challenge due to their biological diversity (Stiller et al., 2021). Accurate differentiation between benign and malignant soft tissue lesions and reliable histological grading are essential for appropriate treatment planning, surgical strategy, and prognosis assessment. Conventional magnetic resonance imaging (MRI) provides excellent anatomical detail; however, it is often limited in its ability to reliably distinguish between benign and malignant lesions based solely on morphological characteristics.
Article Details
Как цитировать:
Библиографические ссылки:
Stiller, C. A., et al. (2021). Epidemiology of Soft Tissue Sarcomas: A Global Perspective. Cancer Epidemiology. https://doi.org/10.1016/j.canep.2021.101990
Gronchi, A., et al. (2023). Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. https://doi.org/10.1016/j.annonc.2023.02.005
Messiou, C., et al. (2017). Advanced imaging in soft tissue sarcoma. Radiology. https://doi.org/10.1148/radiol.2017161754
Koh, D. M., & Collins, D. J. (2007). Diffusion-weighted MRI in the body: applications and challenges. American Journal of Roentgenology. https://doi.org/10.2214/AJR.06.1403
O’Sullivan, P. J., et al. (2015). Imaging of soft-tissue tumors. Radiologic Clinics of North America. https://doi.org/10.1016/j.rcl.2015.05.001